Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation

Resistance is a major concern when administering chemotherapy to patients with non-small cell lung cancer (NSCLC). Chemosensitizer are agents that can reverse resistance to chemotherapeutic drugs, thereby enhancing the chemosensitivity of tumor cells. Thus, their development will improve therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, He, Lian-Jun, Zhu, Yi-Bao, Fan, Qing-Zhu, Miao, Dong-Dong, Zhang, Sheng-Peng, Zhao, Wen-Ying, Liu, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798055/
https://www.ncbi.nlm.nih.gov/pubmed/31680961
http://dx.doi.org/10.3389/fphar.2019.01178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798055/
https://www.ncbi.nlm.nih.gov/pubmed/31680961
http://dx.doi.org/10.3389/fphar.2019.01178

Ejemplares similares